NYSE
Regeneron Pharmaceuticals
$193.82
+4.66 (2.46%)
غير متصل
Bull Bear Scale
REGN
56
score
Price action
193.82
+4.66 (+2.46%)1D
Market closed · Fri, Sep 18, 9:30 AM–4:00 PM ET
Click and drag to measure a move.Use two fingers to measure a move.
جارٍ إعادة الاتصال…
No messages yet
Say hi to everyone on Bull or Bear.
شريط الأرباح والخسائر المباشر
صفقات حقيقية على REGN مع أرباح وخسائر حسب التكلفة
غير متصل
Your vote
One call per vote type per day — tap again to clear, or the other side to flip. Free accounts get 5 new calls/day across the app.
Sentiment desk
Crowd pulse, competing narratives, split news, and labeled street takes — so you can weigh bull and bear without leaving the page.
Our data
56
Crowd lean and tape are rhyming — conviction feels cleaner.
Desk signals
Crowd and tape both lean bull — confirmation, not a free lunch.
56% bull · 44% bear
Contest heat
Knife fight
Street mix
Street mixed
Vote fuel
Quiet room
Living narrative
Two briefs that rotate as the day’s story shifts — not a single merged take.
Bulls say
The bull case treats pullbacks as inventory to absorb — structure intact, buyers still showing up on weakness.
Updates with today’s narrative
Bears say
Cautious framing: narrative got ahead of price. They’re waiting for a clean break, not shorting noise.
Updates with today’s narrative
Split view
Scroll each column on its own so you can compare framing side by side.
Bull-framed
Street note: upside skew still favors Regeneron Pharmaceuticals
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
REGN: constructive base, bulls keep the benefit of the doubt
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
Options flow: call interest rebuilding in REGN
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Why dip-buyers still want REGN on weakness
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Positioning check — REGN longs not as crowded as the timeline
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Bear-framed
Supply check: who is selling REGN into strength?
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Regeneron Pharmaceuticals — failed breakout risk still on the table
Bear briefs stress distribution tells and soft follow-through — green prints as liquidity, not confirmation.
Put buyers quietly rebuilding in REGN
Put-side framing: wait for confirmation. Until then, strength is for trimming, not adding.
REGN bounce looks fragile — bears want lower highs
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Valuation overhang: the case against chasing Regeneron Pharmaceuticals
Bear briefs stress distribution tells and soft follow-through — green prints as liquidity, not confirmation.
Cashtag chatter
Demo feed
Short takes labeled bull or bear. Demo stream until a live social feed is connected.
If $REGN holds this shelf, bulls stay in control.
Not short yet on $REGN — waiting for the break, not the headline.
Valuation + soft follow-through. $REGN still a fade for me.
If $REGN holds this shelf, bulls stay in control.
If $REGN holds this shelf, bulls stay in control.
Lower high forming in $REGN. Patience > FOMO.
$REGN bounce = exit liquidity until proven otherwise.
Adding a starter in $REGN — want follow-through, not hopium.
Relative strength in $REGN vs peers is the tell.
If $REGN holds this shelf, bulls stay in control.
Still long $REGN. Weak opens = inventory.
Lower high forming in $REGN. Patience > FOMO.
Crowd is noisy but the tape in $REGN is cleaner than Twitter.
Crowded long narrative in $REGN. That’s the risk.
Mock profile for REGN used for swipe and chart demos.
Bull or Bear للترفيه والنقاش فقط — وليس نصيحة استثمارية. الشروط · الخصوصية · Safety. قد تكون أسعار السوق محاكاة أو متأخرة.
